Zuivering van drainwater in een beekbegeleidend rietmoeras

In Noord-Limburg liggen intensieve landbouwgebieden met een hoge belasting van het oppervlaktewater met fosfor. In 2006 is in één van die gebieden een rietmoeras aangelegd om de zuiveringsefficientie van fosfor uit drainwater in de praktijk te testen. Het moeras ligt aan de Eeuwelsche Loop in de buurt van Ospel. De Eeuwselsche Loop stroomt vanuit een landbouwgebied door het natuurgebied de Groote Peel naar de Aa in Brabant. De inrichting van het moeras is opgezet om een maximale hoeveelheid fosfor te verwijderen. De eerste resultaten zijn veelbelovend. Van het aangevoerde stikstof bedraagt de zuiveringsefficiëntie circa 30 procent en voor fosfor 50 procent. De rietgroei kwam moeizaam op gang en heeft nog niet zijn maximale productie bereikt. Het oppervlaktebeslag is twee procent en door de ligging aan de Eeuwelsche Loop biedt het ook ruimte voor waterberging en biodiversiteit van natte systemen. Mogelijkheden voor hergebruik van het maaisel en het ijzergruis kan de aanleg van meer rietmoerassen wellicht stimuleren

Effects of Handrail and Cane Support on Energy Cost of Walking in People With Different Levels and Causes of Lower Limb Amputation

Objective: The energy cost of walking with a lower limb prosthesis is higher than able-bodied walking and depends on both cause and level of amputation. This increase might partly be related to problems with balance control. In this study we investigated to what extent energy cost can be reduced by providing support through a handrail or cane and how this depends on level and cause of amputation. Design: Quasi-experimental study. Setting: Rehabilitation gait laboratory. Participants: Twenty-six people with a lower limb amputation were included: 9 with vascular and 17 with nonvascular causes, 16 at transtibial, and 10 at transfemoral or knee disarticulation level (N=26). Interventions: Participants walked on a treadmill with and without handrail support and overground with and without a cane. Main Outcome Measures: Energy cost was assessed using respirometry. Results: On the treadmill, handrail support resulted in a 6% reduction in energy cost on average. This effect was attributed to an 11% reduction in those with an amputation attributable to vascular causes, whereas the nonvascular group did not show a significant difference. No interaction with level of amputation was found. Overground, no main effect of cane support was found, although an interaction effect with cause of amputation demonstrated a small nonsignificant decrease in energy cost (3%) in the vascular group and a significant increase (6%) in the nonvascular group when walking with a cane. The effect of support was positively correlated with self-selected walking speed. Conclusions: This study demonstrates that providing external support can contribute to a reduction in energy cost in people with an amputation due to vascular causes with reduced walking ability while walking in the more challenging condition of the treadmill. Although it is speculated that this effect might be related to problems with balance control, this will need further investigation

Solar active regions: a nonparametric statistical analysis

The sunspots and other solar activity indicators tend to cluster on the surface of the Sun.These clusters very often occur at certain longitudes that persist in time.It is of general interest to find new and simple ways to characterize the observed distributions of different indicators and their behaviour in time. In the present work we use Greenwich sunspot data to evaluate statistical but not totally coherent stability of sunspot distribution along latitudes as well as longitudes. The aim was to obtain information on the longitudinal distribution of the underlying spot-generating mechanism rather than on the distribution and migration of sunspots or sunspot groups on the solar surface. Therefore only sunspot groups were included in the analysis, and only the time of their first appearance was used. We use simple nonparametric approach to reveal sunspot migration patterns and their persistency. Our analysis shows that regions where spots are generated tend to rotate differentially as the spots and spot groups themselves do. The activity areas, however, tend to break down relatively fast, during 7-15 solar rotations. This study provides a challenge for solar dynamo models, as our results are consistent with the presence of a non-axisymmetric spot-generating mechanism experiencing differential rotation (known as phase mixing in dynamo theory). The new nonparametric method introduced here, completely independent of the choice of the longitudinal distribution of sunspots, was found to be a very powerful tool for spatio-temporal analysis of surface features.Comment: 8 pages, 11 figures, submitted to Astronomy and Astrophysic

Bifidobacterium animalis subsp. lactis Bi-07 contributes to increasing lactose digestion: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from DuPont Nutrition Biosciences ApS submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Bifidobacterium animalis subsp. lactis Bi-07 (Bi-07) and contribution to increasing lactose digestion. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is Bi-07. The Panel considers that Bi-07 is sufficiently characterised. The claimed effect proposed by the applicant is \u2018improvement of lactose digestion\u2019. The Panel considers that increasing lactose digestion is a beneficial physiological effect for individuals with lactose maldigestion provided that the symptoms of lactose maldigestion are improved. Two human intervention studies which investigated a single dose effect of Bi-07 on lactose digestion using the hydrogen breath test, as well as on gastrointestinal symptoms were submitted. These studies show that consumption of Bi-07 (1012 CFU) increases lactose digestion in individuals with lactose maldigestion and that Bi-07 exhibits lactase activity in vitro. However, these studies provide no evidence that increasing lactose digestion through the consumption of Bi-07 (1012 CFU) improves gastrointestinal symptoms of lactose maldigestion, which is considered a beneficial physiological effect. The Panel concludes that a cause and effect relationship has not been established between the consumption of Bifidobacterium animalis subsp. lactis Bi-07 and a beneficial physiological effect (i.e. the improvement of symptoms of lactose maldigestion) in individuals with lactose maldigestion

Image potential states of germanene

We have measured the two-dimensional image potential states (IPS) of a germanene layer synthesized on a Ge2Pt crystal using scanning tunnelling microscopy and spectroscopy. The IPS spectrum of germanene exhibits several differences as compared to the IPS spectrum of pristine Ge(001). First, the n = 1 peak of the Rydberg series of the IPS spectrum of germanene has two contributions, labelled n = 1- and n = 1+, respectively. The peak at the lower energy side is weaker and is associated to the mirror-symmetric state with opposite parity. The appearance of this peak indicates that the interaction between the germanene layer and the substrate is very weak. Second, the work function of germanene is about 0.75 eV lower in energy than the work function of Ge(001). This large difference in work function of germanene and pristine Ge(001) is in agreement with first-principles calculations. © 2020 The Author(s). Published by IOP Publishing Ltd

Choline and contribution to normal liver function of the foetus and exclusively breastfed infants: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006

Following an application from Procter & Gamble BV pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to choline and contribution to normal liver function of the foetus and exclusively breastfed infant. The scope of the application was proposed to fall under a health claim referring to children's development and health. The Panel considers that choline is sufficiently characterised. The claimed effect proposed by the applicant is contribution ‘to normal foetal and infant development, especially liver’. The proposed target population is ‘unborn fetuses and breastfed infants’. Choline is involved in the structure of cell membranes, cell signalling, metabolism and transport of lipids and cholesterol and neurotransmitter synthesis. Although choline can be synthesised de novo by the human body, depletion-repletion studies in humans show that low choline intake leads to liver dysfunction and muscle damage, which are reverted by the administration of dietary choline. For these functions, de novo synthesis of choline by the human body is insufficient and choline must be obtained from dietary sources. No human studies have addressed the effect of low maternal dietary choline intake on liver function in the fetus or exclusively breastfed infants. However, the Panel considers that the biological role of choline in normal liver function and dietary choline being essential for the function applies to all ages, including fetus and infants. The Panel concludes that a cause and effect relationship has been established between the intake of choline by pregnant and lactating women and contribution to normal liver function of the fetus and exclusively breastfed infants

Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from BioGaia AB submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Sweden, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The Panel considers that orodispersible lozenges containing L. reuteri DSM 17938 and L. reuteri ATCC PTA 5289 are sufficiently characterised. Maintenance of normal gum function is a beneficial physiological effect. Out of the two studies from which conclusions could be drawn and that investigated the effect of lozenges containing L. reuteri at the proposed conditions of use (i.e. consumption twice daily) on appropriate gingival outcomes (bleeding on probing (PoB) and gingival index (GI)) in subjects with gingivitis, but without periodontitis, one showed a large effect on BoP and other gingival outcomes and one showed no effect. No effect was found in one study with the use of one lozenge daily. The three studies that investigated, at the proposed conditions of use, modified GI (and not BoP or GI) in subjects with gingivitis, but without periodontitis, or were conducted in patients with periodontitis support an effect of lozenges with L. reuteri on gum function. Some evidence has been provided for mechanisms by which consumption of lozenges containing L. reuteri could improve outcomes of gingivitis in patients with chronic periodontitis but the relevance of such mechanisms for the target population of the claim (i.e. subjects without periodontitis) is unclear. The Panel concludes that the evidence provided is insufficient to establish a cause and effect relationship between the consumption of orodispersible lozenges containing a combination of L. reuteri DSM 17938 and L. reuteri ATCC PTA 5289 and maintenance of normal gum function